MICROBE 0 - Microbiotics In Recurrent Clostridium difficile infection: Restoration Of Bacteria: An Investigator-Initiated Open Label Study to Evaluate the Tolerability Safety and Efficacy of FIN-403 in the Prevention of Recurrent CDI
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to evaluate the short-term safety of FIN-403 in patients with recurrent Clostridium difficile infection (CDI); to evaluate how well FIN-403 works in patients with recurrent CDI; to evaluate time to CDI recurrence after taking FIN-403; and to assess the impact of FIN-403 on quality of life.
Description
The purpose of this study is to evaluate the short-term safety of FIN-403 in patients with recurrent Clostridium difficile infection (CDI); to evaluate how well FIN-403 works in patients with recurrent CDI; to evaluate time to CDI recurrence after taking FIN-403; and to assess the impact of FIN-403 on quality of life.
Details
| Condition | Clostridium difficile infection |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX8171 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.